MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that it has signed an agreement with DEXA+ to distribute Hologic’s Horizon ® DXA system for body composition ...

Dual-energy X-ray absorptiometry (DXA) requires phantoms for quality control and cross-calibration. No commercially available phantoms are designed specifically for whole-body scanning of infants. We ...

Dual energy X-ray absorptiometry (DXA) is a recognized tool for measurement of body composition and provides benefits of low dose radiation, quick scan time and multiple measurement options.

In line with its strategy of portfolio expansion, Hologic Inc. (HOLX) launched its redesigned DXA (dual energy X-ray absorptiometry) imaging system – Horizon. This novel system will be used for the ...

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, ...

On October 4th, in conjunction with the 5th Annual Osteoporosis Symposium, the announcement was made that Hologic, Inc. has donated three more DXA instruments for the diagnosis of osteoporosis in ...

HOLX will discontinue Fluoroscan InSight FD by Sept. 30, 2025 due to low margins and limited growth. Hologic's Skeletal Health sales rose 62.1% in Q3 on Horizon DXA ramp-up, boosting overall ...

Players will be screened in Indian Wells on Hologic’s state-of-the-art DXA technology, providing valuable health and performance insights Partnership introduces new opportunities in the fight against ...